This was a really interesting session. Thanks for the great presentations Robin Cash Shan Siddiqi @shansiddiqi.bsky.social Laura Marzetti (she/her) and Baran Aydogan

Appreciation post for Brainbox Ltd knowing #EEG and #TMS devices inside out (off the back of another problem solved by Mark) - Invaluable, unbeatable support if you're doing #electrophysiology research - They don't just sell you the device and leave you stranded 👏⚡️🧲

It's always nice to promote our team's academic achievements and activities. Dr Roisin McMackin always gives a good talk. #BBIconf22

Congratulations to our sister company Brainbox Ltd for taking the leap to open a US office. A truly amazing achievement! linkedin.com/feed/update/ur…

Well done Dr Roisin McMackin A well deserved promotion!

Pharmaceutical companies are turning to a combination of TMS and EEG to test the safety and efficacy of their drugs. #drugdevelopment #TMS #EEG ow.ly/vYKo50MssMS

Thrilled to announce that we've won the Best Early Phase Neuroscience Clinical Trials CRO at the European Enterprise Awards! A huge thank you to our team & partners for their hard work & dedication 🎉💪 #neuroscience #clinicaltrials #awardwinning tinyurl.com/3rm9br9h

Brainbox Initiative Brainbox Ltd Can confirm that the Brainbox Initiative Brainbox Ltd t-shirts look incredible. Better yet, the initiative provides unparalleled opportunities for early career investigators. Great chatting with @andrewt197, Dan, and Mark and hearing more about their vision for the field!

It is now #RareDiseaseDay across the globe 🌍 📌 Organise and post your event: cutt.ly/98d6NtE ✨ Join the Global Chain of Lights & #LightUpForRare: cutt.ly/zPlxnHb 📖 Share your story: cutt.ly/s8d612W 🔥 Share our resources: cutt.ly/M8d69nH

Today is #RareDiseaseDay. Did you know that motor neurone disease is considered a rare condition? We estimate that a person's lifetime risk of developing #MND is around 1 in 300. Not enough people know this, so let's make more aware. Please retweet our graphic 💙 thank you!

It's Rare Disease Day today. Find out how we're supporting a rare disease clinical trial here tinyurl.com/2p9aeyj3 #rarediseaseday #rarediseases #neuroscience #brainresearch #tms #EEG

We're super proud to be supporting this Cardiff University clinical trial with neurophysiological screening and monitoring in partnership with Simbec-Orion #clinicaltrials #neuroscience #schizophrenia #pharmaceuticals #drugresearch cardiff.ac.uk/news/view/2705…

Will you be in London early October? We exhibiting at the 6th Annual MarketsandMarkets Neuroscience R&D Conference. Register here: events.marketsandmarkets.com/6th-neuroscien… #neuroscience #drugdevelopment #clinicalresearch #clinicaltrials

A really interesting article from Simbec-Orion. We, at The Science Behind, work closely with Simbec to support small biotech or pharmaco with CNS related drugs to help ensure they have meaningful PD data from clinical trials. simbecorion.com/nonclinical-de…

Interesting and alarming findings in this study. Will look forward to seeing where this avenue of study leads humanity. #neuroscience #neurodegeneration

We're delighted to announce that we'll be exhibiting at BIO 2023 this year. Visit us on Booth 2085 at the Wales Pavillion. We'd love to talk to you about your upcoming early phase CNS clinical trials. #BIO2023 #BIOInternationalConvention #clinicaltrials #neuroscience

Read our latest article on how standardised cognitive tests and neuroimaging techniques like EEG can enhance information about drug abuse potential of new drugs and new drug formulations. lnkd.in/eYY58wNx #clinicaltrials #drugabusepotential #neuroscience #clinicalresearch

Paired with assisted therapies, psilocybin has been shown to positively affect patient outcomes for those with treatment resistant psychiatric conditions and here's maybe why tinyurl.com/mserxdph

We're delighted to announce that we will be attending BIO-Europe 2024 in Stockholm, Sweden 4-6th November. #clinicaltrials #drugdevelopment #neuroscience #BIOEurope

Glial Cells Play Key Role in Alzheimer’s Development New research has revealed that glial cells, particularly oligodendrocytes, also produce amyloid beta, a protein linked to Alzheimer’s disease. Previously, neurons were considered the primary source of amyloid beta, but this